Articles On Opthea (ASX:OPT)

The S&P/ASX 200 Index (ASX: XJO) is on course to record another small gain. In afternoon trade, the benchmark index is up 0.3% to 8,281.6 points. Four ASX shares that are rising more than most today are listed below. Here's why they a...

Although the share market is close to a record high, that doesn't mean there aren't cheap ASX shares out there. For example, the two shares listed below are being described as cheap by a leading broker. Here's what it is saying: IDP Educat...

Morgans sees opportunities among several ASX healthcare stocks in 2025 Broker looking at stocks with near-term catalysts or sold down with good entry opportunities Morgans’ Christmas stocking has mix of up-and-comers alongside mature names...

ASX gives back gains ahead of Fed decision Vulcan and DigiCo rise MinRes completes $780m gas deal with Hancock Prospecting   The ASX gave back its earlier gains this afternoon as investors adopted a more cautious approach ahead of the US...

 Percheron’s Duchenne muscular dystrophy trial has been a compete flop Canaccord Genuity says Opthea shares are worth at least double their current price Neurizon asks US regulator for motor neurone disease trial go-ahead   Firstly, full...

Race Oncology has appointed experienced biotech executive Dr Megan Baldwin as a non-executive director Baldwin has more than 25 years’ experience in therapeutic drug development for oncology and opthalmology She is the founder and chief in...

From artificial intelligence (A.I) to zygotes, the biotech sector this year delivered the A to Z of excitement, intrigue, occasional disappointment and downright disaster. His virtual stethoscope on hand, Dr Boreham was on duty to diagnose...

Syntara aims for FDA ‘breakthrough’ therapy status for its myelofibrosis drug candidate FAK! More promising results from Amplia’s pancreatic cancer trial Oh, you shouldn’t have! Broker Morgans’ Christmas biotech hamper   Armed with encour...

The S&P/ASX 200 Health Care Index rose 2.89% in November as momentum returned to the sector Health cryogenic services company Vitrafy and nerve-repair biotech Renerve debuted on the ASX  Paradigm Biopharmaceuticals rose 151% in Novembe...

ASX All Ords share Healius Ltd (ASX: HLS) has taken a significant tumble on Friday amid the company holding its annual general meeting (AGM). Healius shares fell to an intraday low of $1.31, down 17.6% on yesterday's closing price....

ASX small-cap stock Findi Ltd (ASX: FND) is surging on Friday and is now 13% higher following an announcement. The company advised of an acquisition that promises to ramp up its cash flows and earnings in India. Investors have bid the st...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a solid gain. At the time of writing, the benchmark index is up 0.4% to 8,259.4 points. Four ASX shares that have failed to follow the market higher today are...

Peninsula Energy Ltd (ASX: PEN) shares are taking a beating on Friday. At the time of writing, the ASX uranium share is down a whopping 25% to a 52-week low of 6.2 cents. Why is this ASX uranium share crashing? Investors have been rushing t...

Opthea (ASX:OPT), a clinical-stage biopharmaceutical company based in Melbourne, has announced a boost to its cash reserves, receiving a $15.9m research and development (R&D) tax incentive from the Australian Taxation Office. The fundin...

EZZ and LTR are among eight ASX companies elevated to the MISC World Microcap Index  Truscreen exceeds budgeted sales of its cervical cancer screening tool in China  Nanosonics says its June half sales recovery has continued   Erectile dy...

ASX healthcare stocks underperform but optimism grows Uscom, Respiri and Hitiq report mixed results Artrya and Nyrada make key clinical advances   The S&P/ASX 200 Health Care [XHJ] index was down 0.9% gain in October. For the year, th...

The Appen Ltd (ASX: APX) share price has been on fire in recent weeks. Since this time last month, the artificial intelligence (AI) data services company's shares have risen 68%. This means that Appen's shares are now up 250% year to date....

Appen Ltd (ASX: APX) shares have been major outperformers in 2024 and are up more than 211% since January. The ASX tech stock has surged more than 106% in the past month alone, as global sentiment around artificial intelligence (AI) cont...

The S&P/ASX All Ordinaries Index (ASX: XAO) closed down 0.68% to 8,416.60 points on Friday. However, these three ASX All Ords health care shares stood out after hitting new 52-week highs. 3 ASX All Ords health care shares that hi...

Healthcare stocks are doing relatively well globally in 2024
 The sector could see more recovery as Fed cuts rates
 How ASX biotechs performed in the month of September   The S&P 500 Health Care Index, a key world benchmark for health...

ASX pharmaceutical shares and other healthcare stocks are off to a positive start on Tuesday. The S&P/ASX 200 Health Care Index (ASX: XHJ) is up 0.46%, while the benchmark ASX 200 is down 0.39%. At the time of writing, health car...

The All Ordinaries Index (ASX: XAO) has gained a healthy 3.8% since 29 July, but this top ASX All Ords stock has left those gains in the dust. The high-flying company in question is Appen Ltd (ASX: APX), which provides data solutions an...

Woolworths Group Ltd (ASX: WOW) shares have come under pressure this week after the grocery giant found itself in hot water, facing both regulatory scrutiny and legal challenges. In case you missed it, the Australian Competition and Con...

The Guzman Y Gomez Ltd (ASX: GYG) share price is being put in the spotlight after one of its major investors decided to make a major sale. The Mexican food business joined the ASX boards three months ago with a lot of attention on its va...

Interest rate cuts have been the talk of the investing town, particularly for those who own ASX dividend shares, over the past few months. This year, we have seen rate cuts from central banks as diverse as the Bank of England, the Bank of C...

Investors who own Coles Group Ltd (ASX: COL) shares are in for a treat this Wednesday. Sure, the Coles share price is having a decent time in today's trading session. At the time of writing, the ASX 200 supermarket blue chip is up a happy 0...

On Tuesday, the S&P/ASX 200 Index (ASX: XJO) had subdued session and dropped into the red. The benchmark index fell 0.1% to 8,142 points. Will the market be able to bounce back from this on Wednesday? Here are five things to watch: AS...

The S&P/ASX 200 Index (ASX: XJO) is out of form again on Tuesday. In afternoon trade, the benchmark index is down 0.5% to 8,111.3 points. Four ASX shares that are falling more than most today are listed below. Here's why they are dropp...

The ASX share market is an excellent tool for growing our wealth. It has been a good time to be an investor – over the last 12 months, the S&P/ASX 200 Index (ASX: XJO) has risen by 15%. Dividend payments have been on top of that retur...

Australians have a number of advantages to help grow their wealth for retirement, such as the capital gains tax discount, franking credits and negative gearing. But there's one strategy in particular that Aussies have at their disposal:...

The ASX200 index is experiencing a decline of approximately half a percent, with Consumer Staples stocks leading the downturn. This decline comes amid ongoing scrutiny from the Australian Competition and Consumer Commission (ACCC) against m...

It was a sobering start to the trading week for the S&P/ASX 200 Index (ASX: XJO) this Monday. After scoring some new record highs last week, investors brought the ASX 200 back down to earth...

It was a great day to have ASX uranium shares in your portfolio. The uranium industry was the standout performer on Monday, with strong gains being recorded across the board. Let's take a quick look at how a number of uranium miners and dev...

With so many shares to choose from on the Australian share market, it can be difficult to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you. Three top ASX shares that leading...

The S&P/ASX 200 Index (ASX: XJO) is having a subdued start to the week. In afternoon trade, the benchmark index is down 0.4% to 8,174.1 points. Four ASX shares that are not letting that hold them back are listed below. Here's why they...

The ASX200 is trading down about half a per cent with Consumer Staples stocks the biggest drag on the index today. It comes as both Woolworths (ASX:WOW) and Coles (ASX:COL) are being pursued by the ACCC over post-COVID marketing campaign...

It was a bouncy but overall positive day for the S&P/ASX 200 Index (ASX: XJO) this Thursday. By the time trading closed, the ASX 200 had climbed by ano...

ASX 200 shares Strike Energy Ltd (ASX: STX) and Sims Ltd (ASX: SGM) are leading the market today with strong share price gains following big news announcements. The S&P/ASX 200 Index (ASX: XJO) is currently up 0.27% to 8,163.8 point...

Lotus Resources Ltd (ASX: LOT) shares are among the best performers on the Australian share market on Thursday. At the time of writing, the ASX uranium stock is up almost 9% to 25 cents. Why is this ASX uranium stock surging? Investors have...

The S&P/ASX 200 Index (ASX: XJO) has given back its early gains and slipped into the red. At the time of writing, the benchmark index is down 0.1% to 8,134.5 points. Four ASX shares that are not letting that hold them back today are l...

Unfortunately for its shareholders, ALS Ltd (ASX: ALQ) shares are being sold off on Thursday morning. In early trade, the ASX 200 share was down as much as 12% to $13.09. Why is this ASX 200 share crashing? Investors have been hitting the s...

So, the US Federal Reserve (their version of our RBA) cut interest rates by 0.5%, overnight. For the first time in four years. It is, make no mistake, a meaningful and consequential change, economically. It suggests that the US Fed believes...

ASX set for shaky start after Powell downplays future rate cuts Wall Street fluctuates post-Fed cut, S&P 500 and Nasdaq end lower Powell emphasises cautious approach, no rush for policy changes ahead   The ASX could be on shaky ground...

The S&P/ASX 200 Index (ASX: XJO) is on course to end the week with a gain. In afternoon trade, the benchmark index is up 0.25% to 8,096.5 points. Four ASX shares that have failed to follow the market higher today are listed below. Here'...

Guzman Y Gomez Ltd (ASX: GYG) shares have continued their positive run and reached a new high of $42.00 on Wednesday. This means the quick service restaurant operator's shares have now almost doubled in value since listing on the ASX boards...

Copper stocks elevated to the S&P/ASX 200 and S&P/ASX 300 including Sandfire Resources and Capstone Copper Corp Radiopharmaceutical company Clarity Pharmaceuticals is among healthcare names elevated to the S&P/ASX 300 Newly lis...

The ASX200 has clawed back earlier losses and closed down 0.32%. The Aussie bourse was driven by quieter than expected by US jobs data which is stoking fears of a recession. Back home, sectors finished a mixed bag, and Discretionary a...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a decline. At the time of writing, the benchmark index is down 0.6% to 7,965.9 points. Four ASX shares that are not letting that hold them back today are liste...

 Clinuvel chairman tells restless investors the company is on track despite share price weakness Opthea to front prestigious New York investment conference Compumedics is back in black as it tackles the sleep home-testing market   Alive a...

It's been a pretty rough start to the trading week for ASX shares so far this Monday. At the time of writing, the S&P/ASX 200 Index (ASX: XJO) has dropped by a hefty 0.9% and is back under 7,945 points. But let's talk about the ARB Corp...